Filer Snapshot

Silo Pharma, Inc.

CIK 0001514183. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

357

Latest filing

16 Apr 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Go to filings Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Forms 3/4/5

424B3 filed on 16 Apr 2026 for CIK 0001514183.

View source filing
Listed symbols
SILO on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
677 N. Washington Blvd, Sarasota, FL, 34236
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
NV
Fiscal year end
31 December
Former names on EDGAR
Uppercut Brands, Inc. (to 14 Aug 2020), Point Capital, Inc. (to 14 May 2019), Gold Swap Inc (to 07 Jan 2013)

Filer intelligence

What SEC filings say about Silo Pharma, Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0001514183 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
357
First seen
30 Mar 2011
Latest filing
16 Apr 2026
Entity
Company

Observed form types

424B3 EFFECT POS AM 8-K 10-K SCHEDULE 13G/A 4 CORRESP SCHEDULE 13G 10-Q +34 more

CIK-linked evidence first

Silo Pharma, Inc. SEC filings Open SEC filing index

Latest Filings

Showing the latest 12 of 357 SEC filings for Silo Pharma, Inc..

Open full filing history
424B3 File 333-286777

PROSPECTUS

Filing date
16 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-286777

EFFECT filing

Filing date
15 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-281692

PROSPECTUS

Filing date
14 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-286777

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
14 Apr 2026
Reporting date
Not listed
Next action
Verify source filing
EFFECT File 333-281692

EFFECT filing

Filing date
13 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-281692

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
10 Apr 2026
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
02 Apr 2026
Reporting date
30 Mar 2026
Next action
Verify source filing
10-K File 001-41512

ANNUAL REPORT

Filing date
27 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-41512

CURRENT REPORT

Filing date
23 Feb 2026
Reporting date
20 Feb 2026
Next action
Verify source filing
SCHEDULE 13G/A File 005-87110

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87110

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87110

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .